Showing results (41-50 of 588) with videos related to
Sort By:
Pageof 59
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1990
Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridizationM Weinreb, D Shinar, G A RodanBiochemical and Biophysical Research Communications|November 13, 1987
Tissue specificity and developmental expression of rat osteopontinK Yoon, R Buenaga, G A RodanThe Journal of Biological Chemistry|December 5, 1988
Cyclic AMP-mediated stabilization of osteocalcin mRNA in rat osteoblast-like cells treated with parathyroid hormoneM Noda, K Yoon, G A RodanClinical Orthopaedics and Related Research|April 1, 1995
Expression and regulation of vascular endothelial growth factor in osteoblastsS Harada, S B Rodan, G A RodanEndocrinology|August 1, 1989
Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bonesM Ernst, J K Heath, G A RodanEndocrinology|February 1, 1988
Effects of retinoic acid on alkaline phosphatase messenger ribonucleic acid, catecholamine receptors, and G proteins in ROS 17/2.8 cellsY Imai, S B Rodan, G A RodanJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1986
Clonal differences in prostaglandin synthesis among osteosarcoma cell linesS B Rodan, G Wesolowski, G A RodanJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 1, 1991
Depression of osteoblastic activity in immobilized limbs of suckling ratsM Weinreb, G A Rodan, D D ThompsonEndocrinology|March 1, 1990
The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow culturesD M Shinar, M Sato, G A RodanOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1993
Preclinical pharmacology of alendronateG A Rodan, J G Seedor, R BalenaPageof 59